Drug development in psoriatic arthritis: a trialtrove-based landscape analysis (1999–2025)
BackgroundPsoriatic arthritis (PsA) is a heterogeneous, immune-mediated disease affecting joints, entheses, the axial skeleton, and skin. Although many targeted therapies have emerged, unmet needs remain in musculoskeletal control, comorbidity manageme…